Literature DB >> 10958889

Differential effects of response-contingent and response-independent nicotine in rats.

E C Donny1, A R Caggiula, C Rose, K S Jacobs, M M Mielke, A F Sved.   

Abstract

Passive administration of nicotine activates the hypothalamic-pituitary-adrenocortical axis and sympathetic nervous system. However, little is known about the effects of self-administered nicotine. Drug-naive rats were trained to respond for food reinforcement and then tested in one, 1-h session in which they received response-contingent i.v. nicotine or response-independent i.v. nicotine or saline. Blood draws were taken immediately prior to the session, 15 min after the first infusion and immediately after the session. Both response-contingent and response-independent nicotine (RI/N) increased corticosterone within 15 min, however, corticosterone levels returned to baseline in animals receiving response-contingent nicotine (RC/N) by the end of the session while remaining elevated in those receiving RI/N. Furthermore, only RI/N increased plasma epinephrine and norepinephrine levels; RC/N produced no effect. These differences indicate that nicotine's acute effects are powerfully modified by the presence of a contingency relationship between drug administration and the animal's behavior and that this relationship develops very rapidly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958889     DOI: 10.1016/s0014-2999(00)00532-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  25 in total

1.  Reward potentiation or behavioral activation? A comment on Donny et al.

Authors:  Hanan Frenk; Reuven Dar
Journal:  Psychopharmacology (Berl)       Date:  2003-10-18       Impact factor: 4.530

2.  Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.

Authors:  Neil E Paterson; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

Review 3.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

4.  The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats.

Authors:  Neil E Paterson; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

5.  A novel method to induce nicotine dependence by intermittent drug delivery using osmotic minipumps.

Authors:  Julia K Brynildsen; Julie Najar; Li-Ming Hsu; D Bruce Vaupel; Hanbing Lu; Thomas J Ross; Yihong Yang; Elliot A Stein
Journal:  Pharmacol Biochem Behav       Date:  2016-01-02       Impact factor: 3.533

6.  The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area.

Authors:  Matthew W Buczynski; Ilham Y Polis; Loren H Parsons
Journal:  Neuropsychopharmacology       Date:  2012-11-21       Impact factor: 7.853

7.  The effects of extended intravenous nicotine administration on body weight and meal patterns in male Sprague-Dawley rats.

Authors:  Patricia E Grebenstein; Ian E Thompson; Neil E Rowland
Journal:  Psychopharmacology (Berl)       Date:  2013-03-14       Impact factor: 4.530

8.  Coadministration of intravenous nicotine and oral alcohol in rats.

Authors:  A D Lê; Steven Lo; Stephen Harding; Walter Juzytsch; Peter W Marinelli; Douglas Funk
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

9.  Self-Administered Nicotine Suppresses Body Weight Gain Independent of Food Intake in Male Rats.

Authors:  Laura E Rupprecht; Tracy T Smith; Eric C Donny; Alan F Sved
Journal:  Nicotine Tob Res       Date:  2016-05-18       Impact factor: 4.244

10.  Voluntary co-consumption of alcohol and nicotine: Effects of abstinence, intermittency, and withdrawal in mice.

Authors:  Kyu Y O'Rourke; Jillienne C Touchette; Elizabeth C Hartell; Elizabeth J Bade; Anna M Lee
Journal:  Neuropharmacology       Date:  2016-06-21       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.